We observed that the KIR3DL1+HLA-Bw4+ and KIR3DL2+HLA-A3/11+ gene combinations were encountered at significantly lower frequency in COVID-19 patients than in the general population. This evidence concerns the gene KIR3DL2 and COVID-19.